MYC and breast carcinoma: By analyzing the proteomic content of EVs extracted from young patients with breast cancers matched with samples of healthy donors, they detected increased levels of Mucin 5b, Mucin 1, TIMP1, Laminin B1, Latent TGFB binding protein1, and Myc target proteins.